243 related articles for article (PubMed ID: 16339689)
21. Genetic variation in mouse beta globin cysteine content modifies glutathione metabolism: implications for the use of mouse models.
Hempe JM; Ory-Ascani J; Hsia D
Exp Biol Med (Maywood); 2007 Mar; 232(3):437-44. PubMed ID: 17327478
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometric quantitation of red blood cell vesicles in thalassemia.
Pattanapanyasat K; Noulsri E; Fucharoen S; Lerdwana S; Lamchiagdhase P; Siritanaratkul N; Webster HK
Cytometry B Clin Cytom; 2004 Jan; 57(1):23-31. PubMed ID: 14696060
[TBL] [Abstract][Full Text] [Related]
23. Exogenous iron increases hemoglobin in beta-thalassemic mice.
Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
[TBL] [Abstract][Full Text] [Related]
24. Transgene copy number-dependent rescue of murine beta-globin knockout mice carrying a 183 kb human beta-globin BAC genomic fragment.
Vadolas J; Wardan H; Bosmans M; Zaibak F; Jamsai D; Voullaire L; Williamson R; Ioannou PA
Biochim Biophys Acta; 2005 May; 1728(3):150-62. PubMed ID: 15820143
[TBL] [Abstract][Full Text] [Related]
25. Coinheritance of the different copy numbers of alpha-globin gene modifies severity of beta-thalassemia/Hb E disease.
Sripichai O; Munkongdee T; Kumkhaek C; Svasti S; Winichagoon P; Fucharoen S
Ann Hematol; 2008 May; 87(5):375-9. PubMed ID: 18026953
[TBL] [Abstract][Full Text] [Related]
26. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand.
Nuntakarn L; Fucharoen S; Fucharoen G; Sanchaisuriya K; Jetsrisuparb A; Wiangnon S
Blood Cells Mol Dis; 2009; 42(1):32-5. PubMed ID: 18951049
[TBL] [Abstract][Full Text] [Related]
27. ENU mutagenesis identifies the first mouse mutants reproducing human β-thalassemia at the genomic level.
Brown FC; Scott N; Rank G; Collinge JE; Vadolas J; Vickaryous N; Whitelaw N; Whitelaw E; Kile BT; Jane SM; Curtis DJ
Blood Cells Mol Dis; 2013 Feb; 50(2):86-92. PubMed ID: 23040355
[TBL] [Abstract][Full Text] [Related]
28. Clinical and hematological phenotype of homozygous hemoglobin E: revisit of a benign condition with hidden reproductive risk.
Tachavanich K; Viprakasit V; Chinchang W; Glomglao W; Pung-Amritt P; Tanphaichitr VS
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):306-16. PubMed ID: 19323016
[TBL] [Abstract][Full Text] [Related]
29. Fermented papaya preparation as redox regulator in blood cells of beta-thalassemic mice and patients.
Amer J; Goldfarb A; Rachmilewitz EA; Fibach E
Phytother Res; 2008 Jun; 22(6):820-8. PubMed ID: 18384199
[TBL] [Abstract][Full Text] [Related]
30. Red blood cell vesicles in thalassemia.
Lamchiagdhase P; Nitipongwanich R; Rattanapong C; Noulsri E; Lerdwana S; Pattanapanyasat K
J Med Assoc Thai; 2004 Mar; 87(3):233-8. PubMed ID: 15117038
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of redox proteins and chaperones in HbEβ-thalassemia erythrocyte proteome.
Bhattacharya D; Saha S; Basu S; Chakravarty S; Chakravarty A; Banerjee D; Chakrabarti A
Proteomics Clin Appl; 2010 May; 4(5):480-8. PubMed ID: 21137065
[TBL] [Abstract][Full Text] [Related]
32. HbE/β-thalassemia: basis of marked clinical diversity.
Olivieri NF; Pakbaz Z; Vichinsky E
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1055-70. PubMed ID: 21075280
[TBL] [Abstract][Full Text] [Related]
33. Effect of alpha-gene numbers on phenotype of HbE/beta thalassemia patients.
Sharma V; Saxena R
Ann Hematol; 2009 Oct; 88(10):1035-6. PubMed ID: 19280189
[No Abstract] [Full Text] [Related]
34. Towards the genetic treatment of beta-thalassemia: new disease models, new vectors, new cells.
Moi P; Sadelain M
Haematologica; 2008 Mar; 93(3):325-30. PubMed ID: 18310536
[No Abstract] [Full Text] [Related]
35. Accelerated telomere shortening in β-thalassemia/HbE patients.
Chaichompoo P; Pattanapanyasat K; Winichagoon P; Fucharoen S; Svasti S
Blood Cells Mol Dis; 2015 Aug; 55(2):173-9. PubMed ID: 25631622
[TBL] [Abstract][Full Text] [Related]
36. Clinical phenotypes and molecular diagnosis in a hitherto interaction of Hb E/beta thalassemia syndrome (beta(E)/beta(-31), (A -->G)).
Vathana N; Viprakasit V; Sanpakit K; Chinchang W; Veerakul G; Tanphaichitr V
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S66-71. PubMed ID: 16856429
[TBL] [Abstract][Full Text] [Related]
37. A novel beta-delta globin gene fusion, anti-Lepore Hong Kong, leads to overexpression of delta globin chain and a mild thalassaemia intermedia phenotype when co-inherited with beta(0)-thalassaemia.
So CC; Chan AY; Tsang ST; Lee AC; Au WY; Ma ES; Chan LC
Br J Haematol; 2007 Jan; 136(1):158-62. PubMed ID: 17222202
[TBL] [Abstract][Full Text] [Related]
38. Hemoglobin C in transgenic mice: effect of HbC expression from founders to full mouse globin knockouts.
Fabry ME; Romero JR; Suzuka SM; Gilman JG; Feeling-Taylor A; Odunusi E; Factor SM; Bouhassira EE; Lawrence C; Nagel RL
Blood Cells Mol Dis; 2000 Aug; 26(4):331-47. PubMed ID: 11042035
[TBL] [Abstract][Full Text] [Related]
39. Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy.
Persons DA; Allay ER; Sabatino DE; Kelly P; Bodine DM; Nienhuis AW
Blood; 2001 May; 97(10):3275-82. PubMed ID: 11342459
[TBL] [Abstract][Full Text] [Related]
40. Transgenic human alpha-hemoglobin stabilizing protein could partially relieve betaIVS-2-654-thalassemia syndrome in model mice.
Wang B; Fang Y; Guo X; Ren Z; Zhang J
Hum Gene Ther; 2010 Feb; 21(2):149-56. PubMed ID: 20063986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
